Skip to main content
Market intelligence
SMMTHealthcare

Summit Therapeutics Inc insider activity

In the last 90 days, 3 corporate insiders purchased $103,616,650 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$103,616,650
Corporate buyers
3
Latest transaction
Jun 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 12, 2026Mahkam ZanganehCo-Chief Executive OfficerOpen Market Purchase3,810,000$13.12$49,987,200
Jun 12, 2026Robert W DugganCo-Chief Executive OfficerOpen Market Purchase3,810,000$13.12$49,987,200
Jun 4, 2026Manmeet Singh SoniCOO and CFOOpen Market Purchase50,000$14.45$722,250